Clinical outcomes in kidney transplant recipients receiving tixagevimab/cilgavimab for outpatient treatment of COVID-19: a single-center retrospective study by Bilgin Osmanodja, Friederike Bachmann, Mira Choi, Wiebke Duettmann, Georgios Eleftheriadis, Fabian Halleck, Marcel G. Naik, Eva Schrezenmeier, Bianca Zukunft, Klemens Budde

Get full text

Association of Blood Donor-derived Cell-free DNA Levels With Banff Scores and Histopathological Lesions in Kidney Allograft Biopsies: Results From an Observational Study by Aylin Akifova, MD, Klemens Budde, MD, Mira Choi, MD, Kerstin Amann, MD, Maike Buettner-Herold, MD, Michael Oellerich, MD, Julia Beck, PhD, Kirsten Bornemann-Kolatzki, PhD, Ekkehard Schütz, PhD, Friederike Bachmann, MD, Fabian Halleck, MD, Eva V. Schrezenmeier, MD, Evelyn Seelow, MD, Bianca Zukunft, MD, Charlotte Hammett, MD, Nathan A. Pohl, Benedetta Mordà, MD, Jan Kowald, MD, Nils Lachmann, Diana Stauch, Bilgin Osmanodja, MD

Get full text

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trialResearch in context by Simone Hoffmann, Eva Schrezenmeier, Maxime Desmarets, Fabian Halleck, Antoine Durrbach, Lynn Peters, Anna-Teresa Tremmel, Alina Seidel, Marita Führer, Friederike Bachmann, Jens Schrezenmeier, Jochen Greiner, Sixten Körper, Henrike Hofmann, Carolin Ludwig, Christiane Vieweg, Bernd Jahrsdörfer, Klemens Budde, Michael Schmidt, Jan Münch, Nizar Joher, Etienne Daguindau, Beate Grüner, Gaëlle Brunotte, Charline Vauchy, Erhard Seifried, Daniel Bradshaw, Lise J. Estcourt, David J. Roberts, Eric Toussirot, Bart Rijnders, Pierre Tiberghien, Hubert Schrezenmeier

Get full text